08:00 , Nov 16, 2015 |  BioCentury  |  Emerging Company Profile

Bridge to POC

BRIM Biotechnology Inc. has assembled a team of translational science veterans to fill what it sees as a gap in Taiwanese drug development capabilities. The company plans to bring in preclinical projects with global commercialization...